186 related articles for article (PubMed ID: 19351919)
1. Provider treatment intensity and outcomes for patients with early-stage bladder cancer.
Hollenbeck BK; Ye Z; Dunn RL; Montie JE; Birkmeyer JD
J Natl Cancer Inst; 2009 Apr; 101(8):571-80. PubMed ID: 19351919
[TBL] [Abstract][Full Text] [Related]
2. Discerning Patterns and Quality of Neoadjuvant Chemotherapy Use Among Patients with Muscle-invasive Bladder Cancer.
Huo J; Ray-Zack MD; Shan Y; Chamie K; Boorjian SA; Kerr P; Jana B; Freedland SJ; Kamat AM; Mehta HB; Williams SB
Eur Urol Oncol; 2019 Sep; 2(5):497-504. PubMed ID: 31411998
[TBL] [Abstract][Full Text] [Related]
3. Patterns of care for early stage bladder cancer.
Strope SA; Ye Z; Hollingsworth JM; Hollenbeck BK
Cancer; 2010 Jun; 116(11):2604-11. PubMed ID: 20310051
[TBL] [Abstract][Full Text] [Related]
4. Understanding the variation in treatment intensity among patients with early stage bladder cancer.
Hollingsworth JM; Zhang Y; Krein SL; Ye Z; Hollenbeck BK
Cancer; 2010 Aug; 116(15):3587-94. PubMed ID: 20564128
[TBL] [Abstract][Full Text] [Related]
5. Identifying better practices for early-stage bladder cancer.
Hollingsworth JM; Zhang YS; Miller DC; Skolarus TA; Wood DP; Lee CT; Montie JE; Hollenbeck BK
Med Care; 2011 Dec; 49(12):1112-7. PubMed ID: 21979371
[TBL] [Abstract][Full Text] [Related]
6. Regional differences in early stage bladder cancer care and outcomes.
Skolarus TA; Ye Z; Zhang S; Hollenbeck BK
Urology; 2010 Aug; 76(2):391-6. PubMed ID: 20394976
[TBL] [Abstract][Full Text] [Related]
7. Use of radical cystectomy for patients with invasive bladder cancer.
Gore JL; Litwin MS; Lai J; Yano EM; Madison R; Setodji C; Adams JL; Saigal CS;
J Natl Cancer Inst; 2010 Jun; 102(11):802-11. PubMed ID: 20400716
[TBL] [Abstract][Full Text] [Related]
8. Does treatment intensity matter in superficial bladder cancer? Consensus, clinical practice, and confounding.
Lyman GH; Kuderer NM; Freedland SJ
J Natl Cancer Inst; 2009 Apr; 101(8):543-5. PubMed ID: 19351926
[No Abstract] [Full Text] [Related]
9. Predictors of intravesical therapy for nonmuscle invasive bladder cancer: results from the surveillance, epidemiology and end results program 2003 patterns of care project.
Huang GJ; Hamilton AS; Lo M; Stein JP; Penson DF
J Urol; 2008 Aug; 180(2):520-4; discussion 524. PubMed ID: 18550088
[TBL] [Abstract][Full Text] [Related]
10. Comparing Survival Outcomes and Costs Associated With Radical Cystectomy and Trimodal Therapy for Older Adults With Muscle-Invasive Bladder Cancer.
Williams SB; Shan Y; Jazzar U; Mehta HB; Baillargeon JG; Huo J; Senagore AJ; Orihuela E; Tyler DS; Swanson TA; Kamat AM
JAMA Surg; 2018 Oct; 153(10):881-889. PubMed ID: 29955780
[TBL] [Abstract][Full Text] [Related]
11. Survival Rates and Health Care Costs for Patients With Advanced Bladder Cancer Treated and Untreated With Chemotherapy.
Flannery K; Cao X; He J; Zhong Y; Shah AY; Kamat AM
Clin Genitourin Cancer; 2018 Aug; 16(4):e909-e917. PubMed ID: 29735397
[TBL] [Abstract][Full Text] [Related]
12. Patterns of use and risks associated with erythropoiesis-stimulating agents among Medicare patients with cancer.
Hershman DL; Buono DL; Malin J; McBride R; Tsai WY; Neugut AI
J Natl Cancer Inst; 2009 Dec; 101(23):1633-41. PubMed ID: 19903808
[TBL] [Abstract][Full Text] [Related]
13. Treatment of nonmuscle invading bladder cancer: do physicians in the United States practice evidence based medicine? The use and economic implications of intravesical chemotherapy after transurethral resection of bladder tumors.
Madeb R; Golijanin D; Noyes K; Fisher S; Stephenson JJ; Long SR; Knopf J; Lyman GH; Messing EM
Cancer; 2009 Jun; 115(12):2660-70. PubMed ID: 19455607
[TBL] [Abstract][Full Text] [Related]
14. Treatment Patterns and Outcomes in Stage IV Bladder Cancer in a Community Oncology Setting: 2008-2015.
Fisher MD; Shenolikar R; Miller PJ; Fenton M; Walker MS
Clin Genitourin Cancer; 2018 Dec; 16(6):e1171-e1179. PubMed ID: 30206026
[TBL] [Abstract][Full Text] [Related]
15. Understanding bladder cancer death: tumor biology versus physician practice.
Morris DS; Weizer AZ; Ye Z; Dunn RL; Montie JE; Hollenbeck BK
Cancer; 2009 Mar; 115(5):1011-20. PubMed ID: 19152434
[TBL] [Abstract][Full Text] [Related]
16. Healthcare Utilization and Costs During the Initial Phase of Care Among Elderly Women With Breast Cancer.
Vyas A; Madhavan SS; Sambamoorthi U; Pan XL; Regier M; Hazard H; Kalidindi S
J Natl Compr Canc Netw; 2017 Nov; 15(11):1401-1409. PubMed ID: 29118232
[No Abstract] [Full Text] [Related]
17. Treatment Patterns and Overall Survival Outcomes of Octogenarians with Muscle Invasive Cancer of the Bladder: An Analysis of the National Cancer Database.
Fischer-Valuck BW; Rao YJ; Rudra S; Przybysz D; Germino E; Samson P; Baumann BC; Gay H; Michalski J
J Urol; 2018 Feb; 199(2):416-423. PubMed ID: 28842247
[TBL] [Abstract][Full Text] [Related]
18. Adherence to surveillance among patients with superficial bladder cancer.
Schrag D; Hsieh LJ; Rabbani F; Bach PB; Herr H; Begg CB
J Natl Cancer Inst; 2003 Apr; 95(8):588-97. PubMed ID: 12697851
[TBL] [Abstract][Full Text] [Related]
19. The Cost to Medicare of Bladder Cancer Care.
Sloan FA; Yashkin AP; Akushevich I; Inman BA
Eur Urol Oncol; 2020 Aug; 3(4):515-522. PubMed ID: 31412015
[TBL] [Abstract][Full Text] [Related]
20. Impact of Adjuvant Intravesical Bacillus Calmette-Guérin Treatment on Patients with High-Grade T1 Bladder Cancer.
Novotny V; Froehner M; Ollig J; Koch R; Zastrow S; Wirth MP
Urol Int; 2016; 96(2):136-41. PubMed ID: 26789626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
